Version 1
: Received: 3 May 2023 / Approved: 4 May 2023 / Online: 4 May 2023 (04:25:54 CEST)
How to cite:
Šoša, I. Cross-Sectional Use of Vascular, Blood-Based Biomarkers—Augmenting Postmortem. Preprints2023, 2023050188. https://doi.org/10.20944/preprints202305.0188.v1
Šoša, I. Cross-Sectional Use of Vascular, Blood-Based Biomarkers—Augmenting Postmortem. Preprints 2023, 2023050188. https://doi.org/10.20944/preprints202305.0188.v1
Šoša, I. Cross-Sectional Use of Vascular, Blood-Based Biomarkers—Augmenting Postmortem. Preprints2023, 2023050188. https://doi.org/10.20944/preprints202305.0188.v1
APA Style
Šoša, I. (2023). Cross-Sectional Use of Vascular, Blood-Based Biomarkers—Augmenting Postmortem. Preprints. https://doi.org/10.20944/preprints202305.0188.v1
Chicago/Turabian Style
Šoša, I. 2023 "Cross-Sectional Use of Vascular, Blood-Based Biomarkers—Augmenting Postmortem" Preprints. https://doi.org/10.20944/preprints202305.0188.v1
Abstract
Many assets of clinical medicine, such as clinical chemistry and diagnostic imaging, make clinical diagnosis outstanding compared to postmortem diagnosis. An assessment of functional status certainly has priority over the postmortem, cross-sectional use of diagnostic tests and laboratory equipment. In addition, the cost of these tools is sometimes steep, and their use does not always fit into a reasonable cost–benefit ratio. However, sometimes postmortem observations, such as inflammation, pulmonary edema, or infiltration and cerebral swelling, cannot be explained without implementing immunohistochemical markers for postmortem diagnosis. Introducing blood-based biomarkers in postmortem care could significantly reduce the rates of inconclusive postmortems and discrepancies in autopsy findings and clinical diagnoses. This is particularly relevant in the scope of vascular pathology, considering the great burden of vascular diseases in overall mortality. Expanding traditional autopsy with blood-based (circulating) biomarkers to avoid invasive postmortem examination would have cultural, religious, and potential economic advantages. All of the target molecules are discussed in the context of the process they up-regulate or down-regulate and which turns out to be the final cause of death. Ultimately, it is evident that further studies are needed to provide concrete validation for a combination of markers on a specific case order to reach a postmortem diagnosis with or without clinical records.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
